Anzeige
Mehr »
Login
Sonntag, 26.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
420 Leser
Artikel bewerten:
(2)

ThetaRay Chooses Screena as Sanctions List Screening Solutions Partner

Finanznachrichten News

Best-Of-Breed AI-Based Providers Collaborate to Deliver
an Integrated Saas Solution for the Fintech Market

NEW YORK and TEL AVIV and LUXEMBOURG, April 6, 2022 /PRNewswire/ -- ThetaRay, a leading provider of AI-powered transaction monitoring technology, today announced it is partnering with next-gen sanctions screening company Screena. Through the alliance, Screena's cloud-based AI-driven screening system will be fully integrated into ThetaRay's SONAR SaaS transaction monitoring solution, providing fintechs and banks with a holistic view of transactional and sanctions list risks.

ThetaRay's SONAR is the industry's most advanced financial crime prevention solution for global payments. Screena's real-time, AI-powered solution uses proprietary algorithms and risk analysis to screen transactions against financial sanctions watchlists with a high degree of precision. The combined transaction monitoring and integrated screening solution can be deployed within weeks.

"The financial world is facing the unprecedented challenge of implementing sanctions that require high-level automation and accuracy, yet ensure the smooth flow of transactions," said Cédric Iggiotti, CEO of Screena. "Screening is the first line of defense against sanctioned countries, individuals, groups, and companies, which are being added around the clock by various global authorities. However, speed and precision are major necessities today. Financial institutions cannot afford 2-5 days for the compliance department to investigate; customers will not stand for it."

SONAR uses an advanced form of AI called "artificial intelligence intuition" to analyze transactions, risk indicators and client data to detect suspicious activities across complex, cross-border transaction paths -- including the use of shell people and companies.

"The only way to accurately monitor the financial activities of sanctioned entities without causing pain to ordinary people is by leveraging advanced AI-powered capabilities," said Mark Gazit, ThetaRay CEO. "ThetaRay and Screena are partnering to help establish a new level of trust in the global financial system. We are committed to enabling unimpeded business and the flow of currencies while preventing money launderers and sanctioned parties from exploiting banks and payments fintechs for illegal activities. We know that the bad guys are using AI, so it is our responsibility to use the most advanced machine learning capabilities available to defend our banking system against them."

The ThetaRay system can identify sophisticated attempts to circumvent economic and trade sanctions and helps governments and financial institutions maintain smooth and uninterrupted global banking activities.

"ThetaRay has teamed up with Screena as the perfect partner to deliver value to our customers through one effective platform that accelerates the investigation process into suspected financial crimes and sanctions violations," said Dagan Osovlansky, Chief Product Officer, ThetaRay. "Cloud-based AML and screening enables fintechs especially to ramp up quickly and grow business opportunities in the financial ecosystem while instilling a new level of trust for global payments."

For more information, visit thetaray.com.

For more information on Screena, please visit https://screena.ai/.

About Screena
Screena empowers banks, fintechs, and digital businesses to quickly and easily integrate name screening and entity resolution with any customer onboarding or payment platform. Screena's innovative technology stops wrongdoers without afflicting legitimate parties, allowing smooth customer registration and fast payment operations. Screena's AI-driven algorithms surface true positives with unrivaled precision and de-risk financial organizations from regulatory fines, personal liability, and reputational damage. Screena can be integrated with third-party systems in a matter of days. Its API-first solution combines extreme configurability and scalability to keep ahead of changing regulation while drastically reducing the cost of financial crime compliance.

About ThetaRay
ThetaRay's AI-powered SONAR transaction monitoring solution, based on "artificial intelligence intuition," allows banks and fintechs to expand their business opportunities through safe and reliable cross-border payments. The groundbreaking solution also improves customer satisfaction, reduces compliance costs, and increases risk coverage. ThetaRay's technology is the only SaaS offering that analyzes SWIFT traffic, risk indicators and client/payer/payee data to detect anomalies indicating money laundering activity across complex, cross-border transaction paths in a single unified platform. Financial organizations that rely on highly heterogeneous and complex ecosystems benefit greatly from ThetaRay's unmatchable low false positive and high detection rates.

© 2022 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.